Pfizer launches major registry to map rare heart disease journey
NCT ID NCT06651073
Summary
This study aims to learn more about a rare heart condition called ATTR-CM by observing 350 patients in Asia. It will not test any new treatments. Instead, it will collect information on how the disease progresses and what treatments patients receive in real-world medical care to help improve future patient management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University
Taipei, 100225, Taiwan
Conditions
Explore the condition pages connected to this study.